Your Article Summary
See Latest ArticlesPemphigus-like lesions induced by imiquimod
Clinical and Experimental Dermatology, 06/15/09
Bauza A et al. - The authors present the case of a 60-year-old woman who, after the application of two sachets of imiquimod cream per day for 5 days/week to two large sBCCs, developed pemphigus-like lesions both at and distant from the application site. Two previous cases of imiquimod-induced pemphigus have been reported, but this is the first case with lesions distant from the site of application.
Related Articles
Subcorneal Pustular Dermatosis-Type IgA Pemphigus With Autoantibodies to Desmocollins 1, 2, and 3
Archives of Dermatology, 10/22/09
Relevance Score: 88%
Treatment of pemphigus vulgaris and pemphigus foliaceus
Expert Review of Dermatology, 10/13/09
Relevance Score: 88%
Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype
Clinical and Experimental Dermatology, 11/10/09
Relevance Score: 85%
Demonstration of pemphigus-specific immunofluorescence pattern by direct immunofluorescence of plucked hair
International Journal of Dermatology, 10/28/09
Relevance Score: 85%
Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09
Relevance Score: 85%
Today in Autoimmune/Bullous Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid
Medical Hypotheses, 12/09/09
Genetic basis of oculocutaneous albinism
Expert Review of Dermatology, 12/08/09
Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Dapsone hypersensitivity syndrome in non-leprosy patients: A retrospective study of its incidence in a tertiary referral center in Taiwan
Journal of Dermatological Treatment , 12/11/09
Muscle Weakness After Repeated Injection of Botulinum Toxin Type A Evaluated According to Bite Force Measurement of Human Masseter Muscle
Dermatologic Surgery, 12/10/09
Randomized, Placebo-Controlled Study of a New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety
Dermatologic Surgery, 12/10/09